Liu M, Li Y, Deng Z, Zhang K, Huang S, Xia J
Cell Death Dis. 2025; 16(1):84.
PMID: 39929806
PMC: 11811017.
DOI: 10.1038/s41419-025-07392-8.
Al-Hamaly M, Winter E, Blackburn J
Cancer Biol Ther. 2025; 26(1):2460252.
PMID: 39905687
PMC: 11801350.
DOI: 10.1080/15384047.2025.2460252.
Pastorczak A, Urbanska Z, Styka B, Miarka-Walczyk K, Sedek L, Wypyszczak K
Leukemia. 2024; 38(11):2344-2354.
PMID: 39192035
PMC: 11518979.
DOI: 10.1038/s41375-024-02370-z.
Arjmand F, Shojaei S, Khalili M, Dinmohammadi H, Poopak B, Mohammadi-Yeganeh S
Bioimpacts. 2024; 14(4):28870.
PMID: 39104620
PMC: 11298021.
DOI: 10.34172/bi.2023.28870.
Kim H, Tan T, Lee D, Huang X, Ong J, Kelliher M
Leukemia. 2024; 38(9):1906-1917.
PMID: 38969731
DOI: 10.1038/s41375-024-02331-6.
Homoharringtonine inhibits the NOTCH/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia.
Suo S, Zhao D, Li F, Zhang Y, Rodriguez-Rodriguez S, Truong Nguyen L
Blood. 2024; 144(12):1343-1347.
PMID: 38968151
PMC: 11451333.
DOI: 10.1182/blood.2023023400.
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.
Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang S
Signal Transduct Target Ther. 2024; 9(1):128.
PMID: 38797752
PMC: 11128457.
DOI: 10.1038/s41392-024-01828-x.
Developmental origins shape the paediatric cancer genome.
Chen X, Yang W, Roberts C, Zhang J
Nat Rev Cancer. 2024; 24(6):382-398.
PMID: 38698126
PMC: 11571274.
DOI: 10.1038/s41568-024-00684-9.
Metabolic Profiling as an Approach to Differentiate T-Cell Acute Lymphoblastic Leukemia Cell Lines Belonging to the Same Genetic Subgroup.
Alabed H, Pellegrino R, Buratta S, Lema Fernandez A, La Starza R, Urbanelli L
Int J Mol Sci. 2024; 25(7).
PMID: 38612731
PMC: 11011837.
DOI: 10.3390/ijms25073921.
fusion genes in acute leukemias: genetic characterization of rare cases.
Brunetti M, Andersen K, Spetalen S, Lenartova A, Osnes L, Valerhaugen H
Front Oncol. 2024; 14:1371980.
PMID: 38571499
PMC: 10987735.
DOI: 10.3389/fonc.2024.1371980.
SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies.
William J, Dhar R, Gundamaraju R, Sahoo O, Pethusamy K, Raj A
Front Oncol. 2024; 14:1288501.
PMID: 38559562
PMC: 10978726.
DOI: 10.3389/fonc.2024.1288501.
Regulating TKT activity inhibits proliferation of human acute lymphoblastic leukemia cells.
Huang F, Chang Y, Lin C, Yu S, Fu J, Chou T
Am J Cancer Res. 2024; 14(2):679-695.
PMID: 38455402
PMC: 10915314.
Decoding the genetic symphony: Profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights.
Verma D, Kapoor S, Kumari S, Sharma D, Singh J, Benjamin M
PNAS Nexus. 2024; 3(2):pgae011.
PMID: 38328782
PMC: 10847906.
DOI: 10.1093/pnasnexus/pgae011.
Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T-ALL.
Parriott G, Hegermiller E, Morman R, Frank C, Saygin C, Stock W
Leukemia. 2023; 38(3):491-501.
PMID: 38155245
DOI: 10.1038/s41375-023-02123-4.
Idasanutlin and navitoclax induce synergistic apoptotic cell death in T-cell acute lymphoblastic leukemia.
Johansson K, Zimmerman M, Dmytrenko I, Gao F, Link D
Leukemia. 2023; 37(12):2356-2366.
PMID: 37838759
PMC: 10681904.
DOI: 10.1038/s41375-023-02057-x.
The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development.
de la Cova C
Cells. 2023; 12(17).
PMID: 37681873
PMC: 10486803.
DOI: 10.3390/cells12172141.
A Comprehensive Analysis of the Expression Profiles of KCTD Proteins in Acute Lymphoblastic Leukemia: Evidence of Selective Expression of KCTD1 in T-ALL.
Buono L, Iside C, Pecoraro G, De Matteo A, Beneduce G, Penta de Vera dAragona R
J Clin Med. 2023; 12(11).
PMID: 37297863
PMC: 10253327.
DOI: 10.3390/jcm12113669.
Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia.
Liang H, Kong X, Cao Z, Wang H, Liu E, Sun F
Front Immunol. 2023; 14:1194353.
PMID: 37266435
PMC: 10229868.
DOI: 10.3389/fimmu.2023.1194353.
In the business of base editors: Evolution from bench to bedside.
Porto E, Komor A
PLoS Biol. 2023; 21(4):e3002071.
PMID: 37043430
PMC: 10096463.
DOI: 10.1371/journal.pbio.3002071.
TRIM37 interacts with PTEN to promote the growth of human T-cell acute lymphocytic leukemia cells through regulating PI3K/AKT pathway.
Qu H, Gao-Wa H, Hou Y, Ren M, Li J, Jing B
Front Oncol. 2023; 12:1016725.
PMID: 36923153
PMC: 10009101.
DOI: 10.3389/fonc.2022.1016725.